Raffaele Colombo: Excited to be presenting ADCs at the 36th ENA symposium

The 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics will be held in person at the CCIB in Barcelona in October 2024.

ENA 2024 is a premier event focused on drug development and translational research, emphasizing preclinical and phase I studies and facilitating comprehensive scientific discussions on the latest advances in targets and therapeutics.

This symposium draws a global audience of academics, scientists, and pharmaceutical industry leaders, providing a platform for detailed discussions on cutting-edge innovations in drug development, target selection, and the impact of new molecular biology discoveries.

Raffaele Colombo recently announced his presentation in 36th ENA symposium. Read his post on X below:

Only 2 weeks until the 36th EORTC-NCI-AACR (ENA) Symposium in Barcelona I’m excited to be presenting on ADCs with Paolo Tarantino, Barbara Pistilli and Giuseppe Curigliano during the Plenary Session 2!”

Proceed further to read session details.

More posts featuring Raffaele Colombo on oncodaily.com.

Raffaele Colombo, a leading figure in the pharmaceutical industry is the Associate Director of Medicinal Chemistry at Zymeworks Inc.. His leadership and scientific acumen drive the discovery and optimization of novel drug candidates and advancing the treatment landscape for various diseases.